Cdex, Inc. (fka CDEX)

[d4diddy]

Good interview of Jim Griffin by thewallstreetreporter.com. It appears Griffin is trying to get CDEx better exposure to new investment money, especially institutional.

Highlights:

- strength of interview- selling the bios of the BOD

- 3 million needed in the next 18 months

- breakeven after that

- 200 million in 5 years

- followed by disclaimers

When asked what makes CDEX tech better than others, Griffin focused on Valimed and said it was better than a pharmacist using a refractometer to test the IV solution and it's better than sending a sample to an outside lab which could take days for results. Weak!

I beleive that if he had something unique to say about the technology that was the time to say it. Not impressive, the question should have never been put in the script.

No comparison with other manufacturers of spectral instruments.